This course has expired. View available courses.
Oncology
Update on the treatment of metastatic castration-resistant prostate cancer (mCRPC) – Certificate of Completion
DURATION
PROFESSION
Specialist
# OF CREDITS
2
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2018-08-04
Learning objectives
After completing this module, participants will have enhanced:
- Knowledge of the different modes of action of metastatic castration-resistant prostate cancer (mCRPC) therapies including new agents;
- Familiarity with the clinical data on therapies for mCRPC pre- and post-docetaxel chemotherapy, including efficacy, quality of life and safety.
- Confidence regarding the role of these new medications in pre- and post-chemotherapy management, including when to start and stop treatment.